Analyzing tumor tissue lysates by western blots demonstrated that BRD4-regulate proteins (Bcl-2, Myc, cyclin D1) were significantly downregulated in I-BET726-treated A431 tumor tissues (Fig. 5e). This evidence concerns the gene BRD4 and neoplasm.